TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Chemoform Scandinavia AB
Closing information (x1000 EUR)
Closing information | 2023/10 | 2022/10 | 2021/10 |
Turnover |
6,227
|
9,542
|
11,589 |
Financial expenses |
387
|
60
|
74 |
Earnings before taxes |
-788
|
893
|
1,195 |
EBITDA |
-385
|
976
|
1,299 |
Total assets |
3,878
|
4,747
|
3,493 |
Current assets |
3,830
|
4,670
|
3,460 |
Current liabilities |
2,406
|
2,295
|
1,594 |
Equity capital |
1,472
|
2,330
|
1,787 |
- share capital |
85
|
92
|
101 |
Employees (average) |
17
|
14
![]() |
14 |
Financial ratios
Fiscal year | 2023/10 | 2022/10 | 2021/10 |
Solvency |
38.0%
|
49.1%
|
51.2% |
Turnover per employee |
366
|
682
|
828 |
Profit as a percentage of turnover |
-12.7%
|
9.4%
|
10.3% |
Return on assets (ROA) |
-10.3%
|
20.1%
|
36.3% |
Current ratio |
159.2%
|
203.5%
|
217.1% |
Return on equity (ROE) |
-53.5%
|
38.3%
|
66.9% |
Change turnover |
-2,571
|
-1,029
|
4,460 |
Change turnover % |
-29%
|
-10%
|
63% |
Chg. No. of employees |
3
|
0
|
4 |
Chg. No. of employees % |
21%
|
0%
|
40% |
Total value of public sale
Fiscal year | 2023/10 | 2022/10 | 2021/10 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.